Core B: Transgenic and Gene Targeting Core The Transgenic and Gene Targeting Core integrates with and enhances the capabilities of our exisitng Transgenic and Gene Targeting Facility with a proven track record of success in creating transgenic and knockout mice. This Core will assist COBRE investigators by providing cost-efffective serviecs for the generation, characterization, and maintenance of genetic mouse models. Ofthe 32 senior scientists in the Center, 9 are frequent users ofthe Core, and 2 of the 5 COBRE Beginning Investigator projects also have plans to utilize this facility. This Core will provide COBRE scientists with the service to microinject DNA into fertilized eggs and transfer embryos to recipient females to create transgenic mice. In addition, this Core will provide services to create chimeric mice, including the maintenance of several ES cell lines, electroporation and selection of ES cells, karyotype determination and blastocyst injection of selected ES cells. COBRE funds will be used to expand these services to include the manipulation and preparation of DNA for microinjection or gene targeting, and genotyping of transgenic and knockout mice. The Core also provides cryopreservation of mouse lines. The COBRE funds will subsidize services for Beginning Investigators and Center members and KUMC will continue to provide significant institutional support for this facility. The Facility is staffed by a Technical Director, Scientific Director, and two Research Associates, who will interface with two COBRE co-advisors

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
5P20GM104936-07
Application #
8534216
Study Section
Special Emphasis Panel (ZRR1-RI-B)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
7
Fiscal Year
2013
Total Cost
$159,935
Indirect Cost
$54,018
Name
University of Kansas
Department
Type
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Kumar, T Rajendra (2018) Fshb Knockout Mouse Model, Two Decades Later and Into the Future. Endocrinology 159:1941-1949
Cao, Thuy; Rajasingh, Sheeja; Samanta, Saheli et al. (2018) Biology and clinical relevance of noncoding sno/scaRNAs. Trends Cardiovasc Med 28:81-90
Kumar, Ram P; Ray, Soma; Home, Pratik et al. (2018) Regulation of energy metabolism during early mammalian development: TEAD4 controls mitochondrial transcription. Development 145:
Samanta, Saheli; Rajasingh, Sheeja; Drosos, Nicholas et al. (2018) Exosomes: new molecular targets of diseases. Acta Pharmacol Sin 39:501-513
Chao, Xiaojuan; Wang, Shaogui; Zhao, Katrina et al. (2018) Impaired TFEB-Mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-Induced Liver Injury and Steatosis in Mice. Gastroenterology 155:865-879.e12
Srivastava, Tarak; Dai, Hongying; Heruth, Daniel P et al. (2018) Mechanotransduction signaling in podocytes from fluid flow shear stress. Am J Physiol Renal Physiol 314:F22-F34
Pierce, Angela N; Eller-Smith, Olivia C; Christianson, Julie A (2018) Voluntary wheel running attenuates urinary bladder hypersensitivity and dysfunction following neonatal maternal separation in female mice. Neurourol Urodyn 37:1623-1632
Sharma, Himanshu; Chinnappan, Mahendran; Agarwal, Stuti et al. (2018) Macrophage-derived extracellular vesicles mediate smooth muscle hyperplasia: role of altered miRNA cargo in response to HIV infection and substance abuse. FASEB J 32:5174-5185
Rajasingh, Sheeja; Isai, Dona Greta; Samanta, Saheli et al. (2018) Manipulation-free cultures of human iPSC-derived cardiomyocytes offer a novel screening method for cardiotoxicity. Acta Pharmacol Sin 39:1590-1603
Trembath, Andrew P; Markiewicz, Mary A (2018) More than Decoration: Roles for Natural Killer Group 2 Member D Ligand Expression by Immune Cells. Front Immunol 9:231

Showing the most recent 10 out of 80 publications